Yuhan (000100)

Currency in KRW
81,100
-200(-0.25%)
Delayed Data·
000100 is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
79,70082,100
52 wk Range
65,000122,800
Key Statistics
Bid/Ask
81,000.00 / 81,100.00
Prev. Close
81,300
Open
80,000
Day's Range
79,700-82,100
52 wk Range
65,000-122,800
Volume
72.57K
Average Volume (3m)
248.7K
1-Year Change
-31.7607%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
000100 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
110,882
Upside
+36.72%
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry

Yuhan News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

13 Buy
2 Hold
2 Sell
Ratings:
17 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 110,882
(+36.72% Upside)

Earnings

Latest Release
Nov 16, 2026
EPS / Forecast
295.11 / 378.41
Revenue / Forecast
604.3B / 602.76B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 3,140
Dividend Yield
0.74%
Industry Median 1.31%
Annualized payout
600.00
Paid annually
5-Years Growth
+12.76%
Growth Streak

000100 Income Statement

Compare 000100 to Peers and Sector

Metrics to compare
000100
Peers
Sector
Relationship
P/E Ratio
25.9x6.9x−0.2x
PEG Ratio
0.130.030.00
Price/Book
2.5x0.7x2.6x
Price / LTM Sales
2.7x0.7x2.7x
Upside (Analyst Target)
36.4%61.3%72.2%
Fair Value Upside
Unlock26.7%12.4%Unlock

Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and analytical method development and regulatory support. The company also provides APIs and intermediates, including antibiotic, anti-thrombotic, anti-hyperlipidemics, and anti-hypertensive; and custom synthesis services through commercial supply in areas of anti-viral, anti-HIV, anti-HCV, anti-biotic, antihistamine, anti-diabetic, ß-lactamase inhibitor, CNS intermediate, PEG-compounds, and others. Yuhan Corporation was founded in 1926 and is headquartered in Seoul, South Korea.

Employees
2082

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
9.08M12.15%727.36B
Other Institutional Investors
32.55M43.54%2.61T
Public Companies & Retail Investors
33.13M44.31%2.65T
Total
74.76M100.00%5.99T

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Yuhan Foundation16.97%12,689,2821,016,411,488
Yuhan Academy8.35%6,239,751499,804,055

People Also Watch

215,500
018260
+0.47%
215,000
068270
0.00%
462,000
128940
+9.48%
178,500
196170
+3.36%
111,900
010120
-7.37%

FAQ

What Is the Yuhan (000100) Stock Price Today?

The Yuhan stock price today is 81,100 KRW.

What Stock Exchange Does Yuhan Trade On?

Yuhan is listed and trades on the Seoul Stock Exchange.

What Is the Stock Symbol for Yuhan?

The stock symbol for Yuhan is "000100."

Does Yuhan Pay Dividends? What’s The Current Dividend Yield?

The Yuhan dividend yield is 0.7%%.

What Is the Yuhan Market Cap?

As of today, Yuhan market cap is 6.06T KRW.

What Is Yuhan's Earnings Per Share (TTM)?

The Yuhan EPS (TTM) is 3,140.

When Is the Next Yuhan Earnings Date?

Yuhan will release its next earnings report on Feb 17, 2027.

From a Technical Analysis Perspective, Is 000100 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Yuhan Stock Split?

Yuhan has split 25 times.

How Many Employees Does Yuhan Have?

Yuhan has 2082 employees.

What is the current trading status of Yuhan (000100)?

As of Nov 20, 2026, Yuhan (000100) is trading at a price of 81,100 KRW, with a previous close of 81,300 KRW. The stock has fluctuated within a day range of 79,700 KRW to 82,100 KRW, while its 52-week range spans from 65,000 KRW to 122,800 KRW.

What Is Yuhan (000100) Price Target According to Analysts?

The average 12-month price target for Yuhan is 110,882 KRW, with a high estimate of 145000 KRW and a low estimate of 65000 KRW. 13 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Buy. The stock has an +36.72% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.